Detection of adventitious viruses from biologicals using a broad-spectrum microbial detection array.

Area of Science:

• Microbiology
• Biotechnology
• Genomics

Background:

• Adventitious viruses and bacteria pose significant risks to the safety of biological products.
• Current detection methods can be time-consuming and may not identify novel or divergent microbial species.

Purpose of the Study:

• To develop and evaluate the Lawrence Livermore Microbial Detection Array (LLMDA) for broad-spectrum microbial detection.
• To assess the array's efficacy in identifying adventitious agents in vaccine products and clinical samples.

Main Methods:

• Design of the LLMDA with 388,000 DNA probes targeting a wide range of viral and bacterial species.
• Utilizing oligonucleotide probes for detecting novel and divergent species with homology to known organisms.
• Application of the array for identifying an adventitious virus in a vaccine and detecting infections in human clinical samples.

Main Results:

• The LLMDA successfully identified an adventitious virus in a vaccine product.
• The array demonstrated capability in detecting viral and bacterial infections from various human clinical samples.
• The system achieved detection of sequenced viruses and bacteria within a 24-hour timeframe.

Conclusions:

• Broad-spectrum microbial detection microarrays are efficient and cost-effective tools for rapid screening.
• The LLMDA can significantly contribute to ensuring drug, food, and health safety.
• This technology supports the rapid identification of microbial contaminants in biologics and clinical settings.